Presented by: Preben Rasmussen, PhD and Jakob Poulsen, PhD, VALUA ApS The US market is arguably the most interesting target for most Life-Science companies. US patent law differs markedly from the rest of the world. Thus, a short-term myopic focus on the possibilities for obtaining patent protection in the US

Presenter: James A. Long, Esq. Managing Partner, Long Law This will be an introduction to the risk and pitfalls that might be faced by a biotech startup: specifically, hacking into IoT devices and the proliferation of biometric laws and regulations across the country that would affect biotech companies.   REGISTER